MarketN-Acetylglucosamine
Company Profile

N-Acetylglucosamine

N-Acetylglucosamine (GlcNAc) is an amide derivative of the monosaccharide glucose. It is a secondary amide between glucosamine and acetic acid. It is significant in several biological systems.

Medical uses
It has been proposed as a treatment for autoimmune diseases and recent tests have claimed some success. ==O-GlcNAcylation==
O-GlcNAcylation
O-GlcNAcylation is the process of adding a single N-acetylglucosamine sugar to the serine or threonine of a protein, controlled by a pair of opposing enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Comparable to phosphorylation, addition or removal of N-acetylglucosamine is a means of activating or deactivating enzymes or transcription factors., cancer, and inflammatory diseases such as arthritis Increased O-GlcNAcylation due to hyperglycemia is evidently a dysfunctional form of O-GlcNAcylation. O-GlcNAcylation decline in the brain with age is associated with cognitive decline. When O-GlcNAcylation was increased in the hippocampus of aged mice, spatial learning and memory improved. Furthermore, O-GlcNAcylation may also be involved in cancer pathogenesis, due to its close ties with various nutritional and growth signal transductions. == See also ==
tickerdossier.comtickerdossier.substack.com